Ledger.Open graph →
SEC Form D · filed August 15, 2019

INOVIO PHARMACEUTICALS, INC

Offering
$15.2M
Sold
$15.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Plymouth Meeting, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Jon M. Briggs · Dallas, TXExecEric V. Pauly · Wichita, KSDirectorSarah M. Finn · Denver, CODirectorAmy V. Venturi · Denver, COExecRobert J. Reiter · Denver, CODirectorRuth M. Rohs · Denver, CODirectorThomas M. Reed · Wichita, KSDirectorSueann V. Schultz · Topeka, KSExecMichael L. Benson · Denver, CODirectorKelli M. Mack · Wichita, KSExec · DirectorEdward Kim · San Francisco, CAExecJin Guo · Washington, Washington, D.C.Exec · DirectorJohn Stinebaugh · New York, NYExecJennifer Ritchie · New York, NYDirectorJulian Deschatelets · New York, NYDirectorJessica Diab · New York, NYExecMark Srulowitz · New York, NYDirectorJordan Kolar · New York, NYDirectorKeiji Hattori · New York, NYDirectorMichael Tebbutt · New York, NYDirectorMorton X. Collins · Plymouth Meeting, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗